The complexity of pharmacology of cannabidiol (CBD) and its implications in the treatment of brain disorders

Neuropsychopharmacology. 2020 Jan;45(1):229-230. doi: 10.1038/s41386-019-0518-1.

Sonja Elsaid^{1

2}, Bernard Le Foll^{3

4

5}

¹ Translational Addiction Research Laboratory, Centre for Addiction and Mental Health (CAMH), 33 Russell Street, T-700, Toronto, ON, M5S 2S1, Canada.
² The Institute of Medical Science, Faculty of Medicine, University of Toronto, 27 King's College Circle, Toronto, ON, M5S 1A1, Canada.
³ Translational Addiction Research Laboratory, Centre for Addiction and Mental Health (CAMH), 33 Russell Street, T-700, Toronto, ON, M5S 2S1, Canada. Bernard.lefoll@camh.ca.
⁴ The Institute of Medical Science, Faculty of Medicine, University of Toronto, 27 King's College Circle, Toronto, ON, M5S 1A1, Canada. Bernard.lefoll@camh.ca.
⁵ Departments of Pharmacology & Toxicology, Family and Community Medicine and Psychiatry, University of Toronto, 27 King's College Circle, Toronto, ON, M5S3H7, Canada. Bernard.lefoll@camh.ca.

No abstract available

Publication types